MiRNAs as biomarkers of myocardial infarction: A meta-analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Cheng, Chao ^a   Wang, Qiang ^b   You, Wenjie ^c   Chen, Manhua ^d   Xia, Jiahong ^a,d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 208B; MICRORNA 499; TROPONIN I; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN; TNNT2 PROTEIN, HUMAN; TROPONIN T;

AREA UNDER THE CURVE; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; GENETIC HETEROGENEITY; HEART INFARCTION; HUMAN; META ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RNA DEGRADATION; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; HEART MUSCLE; METABOLISM; METHODOLOGY; MYOCARDIAL INFARCTION; REPRODUCIBILITY; RISK; SAMPLE SIZE;

AREA UNDER CURVE; BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; HUMANS; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 84895755164     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088566     Document Type: Article

References (42)

1. He J, Gu D, Wu X, Reynolds K, Duan X, et al. (2005) Major causes of death among men and women in China. New England Journal of Medicine 353: 1124-1134. (Pubitemid 41317435)
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. (2011) Heart Disease and Stroke Statistics-2011 Update: A Report From the American Heart Association. Circulation 123: e18-e209.
3. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, et al. (2010) Population trends in the incidence and outcomes of acute myocardial infarction. New England Journal of Medicine 362: 2155-2165.
4. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, et al. (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. European heart journal 29: 2909-2945.
5. Chan D, Ng LL (2010) Biomarkers in acute myocardial infarction. BMC medicine 8: 34.
6. Iribarren C, Phelps B, Darbinian J, McCluskey E, Quesenberry C, et al. (2011) Circulating angiopoietins-1 and-2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC cardiovascular disorders 11: 31.
7. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301.
8. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating MicroRNAs in Patients With Coronary Artery DiseaseNovelty and Significance. Circulation research 107: 677-684.
9. Lippi G, Mattiuzzi C, Cervellin G (2012) Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: Meta-analysis of available studies. International journal of cardiology.
10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC medical research methodology 3: 25.
11. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, et al. (2010) Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clinical chemistry 56: 1183-1185.
12. Ai J, Zhang R, Li Y, Pu J, Lu Y, et al. (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and biophysical research communications 391: 73-77.
13. Cheng Y, Tan N, Yang J, Liu X, Cao X, et al. (2010) A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clinical Science 119: 87-95.
14. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circulation: Cardiovascular Genetics 3: 499-506.
15. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, et al. (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. European heart journal 31: 2765-2773.
16. Gidlöf O, Andersson P, van der Pals J, Götberg M, Erlinge D (2011) Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118: 217-226.
17. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, et al. (2011) Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circulation: Cardiovascular Genetics 4: 446-454.
18. Long G, Wang F, Duan Q, Chen F, Yang S, et al. (2012) Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. International Journal of Biological Sciences 8: 811.
19. Long G, Wang F, Duan Q, Yang S, Chen F, et al. (2012) Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PloS one 7: e50926.
20. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, et al. (2011) MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic research in cardiology 106: 13-23.
21. Oerlemans MI, Mosterd A, Dekker MS, de Vrey EA, van Mil A, et al. (2012) Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO molecular medicine 4: 1176-1185.
22. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, et al. (2012) Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. International Journal of Cardiology.
23. Wang G-K, Zhu J-Q, Zhang J-T, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European heart journal 31: 659-666.
24. Wang R, Li N, Zhang Y, Ran Y, Pu J (2011) Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 50: 1789-1795.
25. Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, et al. (2012) Use of circulating microRNAs to diagnose acute myocardial infarction. Clinical chemistry 58: 559-567.
26. Vogel B, Keller A, Frese KS, Kloos W, Kayvanpour E, et al. (2013) Refining diagnostic microRNA signatures by whole-miRNome kinetic analysis in acute myocardial infarction. Clinical chemistry 59: 410-418.
27. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, et al. (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. Journal of Alzheimer's disease 14: 27-41. (Pubitemid 352039013)
28. Wang J, Chen J, Chang P, LeBlanc A, Li D, et al. (2009) MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer prevention research 2: 807-813.
29. de Planell-Saguer M, Rodicio MC (2011) Analytical aspects of microRNA in diagnostics: a review. Analytica chimica acta 699: 134-152.
30. Cissell KA, Rahimi Y, Shrestha S, Hunt EA, Deo SK (2008) Bioluminescence-based detection of microRNA, miR21 in breast cancer cells. Analytical chemistry 80: 2319-2325. (Pubitemid 351499813)
31. Cissell KA, Campbell S, Deo SK (2008) Rapid, single-step nucleic acid detection. Analytical and bioanalytical chemistry 391: 2577-2581.
32. Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, et al. (2009) Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One 4: e5311.
33. Martí E, Pantano L, Bañez-Coronel M, Llorens F, Miñones-Moyano E, et al. (2010) A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic acids research 38: 7219-7235.
34. Lee LW, Zhang S, Etheridge A, Ma L, Martin D, et al. (2010) Complexity of the microRNA repertoire revealed by next-generation sequencing. Rna 16: 2170-2180.
35. Wang Y, Zheng D, Tan Q, Wang MX, Gu L-Q (2011) Nanopore-based detection of circulating microRNAs in lung cancer patients. Nature Nanotechnology 6: 668-674.
36. Zhao Y, Zhou L, Tang Z (2013) Cleavage-based signal amplification of RNA. Nature communications 4: 1493.
37. Gidlöf O, Smith JG, Miyazu K, Gilje P, Spencer A, et al. (2013) Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC cardiovascular disorders 13: 1-9.
38. Li C, Fang Z, Jiang T, Zhang Q, Liu C, et al. (2013) Serum microRNAs profile from genom-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC medical genomics 6: 16.
39. Li Y-Q, Zhang M-F, Wen H-Y, Hu C-L, Liu R, et al. (2013) Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics 68: 75-80.
40. Wang H, Lin Y, Lu H, Zhou Y, Luo C, et al. (2011) Circulating microRNA-92a in patients with ST-segment elevation myocardial infarction. Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 23: 718.
41. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, et al. (2012) Prospective study on circulating microRNAs and risk of myocardial infarction. Journal of the American College of Cardiology 60: 290-299.
42. Boštjančič E, Zidar N, Štajer D, Glavač D (2009) MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115: 163-169.